Advertisement
U.S. markets closed
Advertisement

JanOne Inc. (JAN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
0.5330+0.0650 (+13.89%)
At close: 04:00PM EST
0.5799 +0.05 (+8.80%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Fast Stochastic

Fast Stochastic

Performance Outlook
Previous Close0.4680
Open0.4670
Bid0.5600 x 1300
Ask0.5384 x 1000
Day's Range0.4670 - 0.5350
52 Week Range0.2200 - 2.2300
Volume197,586
Avg. Volume1,207,669
Market Cap2.642M
Beta (5Y Monthly)1.85
PE Ratio (TTM)5.92
EPS (TTM)0.0900
Earnings DateNov 14, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
72% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for JAN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • JanOne Inc.
    Daily – Vickers Top Insider Picks for 12/07/2023The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
  • PR Newswire

    JanOne to Present at the Dawson James 8th Annual Investment Conference

    JanOne (Nasdaq: JAN), the biopharmaceutical company focused on developing non-addicting painkillers and novel treatments for the causes of pain, will participate in investor sessions at the Dawson James Securities 8th Annual Investment Conference in Jupiter, Florida. JanOne's Chief Medical Officer, Dr. Amol Soin, will attend the October 12, day-long conference and present JanOne's mission and progress.

  • GlobeNewswire

    Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference

    JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8th Annual Dawson James Small Cap Growth Conference on October 12, 2023, at the Wyndham Grand Hotel in Jupiter, FL. Dawson James’ flagship Small Cap Growth Conference brings together senior leadership from over 30 of the most innovative companies at the forefront of healthcare, technology and consu

  • PR Newswire

    JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference

    JanOne (Nasdaq: JAN), the biopharmaceutical company focused on developing non-addicting painkillers and novel treatments for the causes of pain, will participate in investor sessions at the H.C. Wainwright 25th Annual Global Investment Conference in New York City. JanOne's Chief Medical Officer, Dr. Amol Soin, will appear via recorded video and attend the conference in person to represent the company's mission and progress.